Nothing Special   »   [go: up one dir, main page]

FI954852A - 1,5-Benzodiazepine derivatives with CCK and / or gastrin antagonist activity - Google Patents

1,5-Benzodiazepine derivatives with CCK and / or gastrin antagonist activity Download PDF

Info

Publication number
FI954852A
FI954852A FI954852A FI954852A FI954852A FI 954852 A FI954852 A FI 954852A FI 954852 A FI954852 A FI 954852A FI 954852 A FI954852 A FI 954852A FI 954852 A FI954852 A FI 954852A
Authority
FI
Finland
Prior art keywords
cck
antagonist activity
benzodiazepine derivatives
gastrin antagonist
gastrin
Prior art date
Application number
FI954852A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI954852A0 (en
Inventor
Harry Finch
Pritom Shah
Robin Arthur Ellis Carr
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939307833A external-priority patent/GB9307833D0/en
Priority claimed from GB9406037A external-priority patent/GB9406037D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of FI954852A publication Critical patent/FI954852A/en
Publication of FI954852A0 publication Critical patent/FI954852A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI954852A 1993-04-15 1995-10-12 1,5-bentzodiazepine derivatives with CCK and / or gastrin antagonistic activity FI954852A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939307833A GB9307833D0 (en) 1993-04-15 1993-04-15 Modulators of cholecystokinin and gastrin
GB9406037A GB9406037D0 (en) 1994-03-29 1994-03-29 1,5 Benzodiazepine derivatives
PCT/EP1994/001130 WO1994024151A1 (en) 1993-04-15 1994-04-13 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity

Publications (2)

Publication Number Publication Date
FI954852A true FI954852A (en) 1995-10-12
FI954852A0 FI954852A0 (en) 1995-10-12

Family

ID=26302765

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954852A FI954852A0 (en) 1993-04-15 1995-10-12 1,5-bentzodiazepine derivatives with CCK and / or gastrin antagonistic activity

Country Status (14)

Country Link
EP (1) EP0694040A1 (en)
JP (1) JPH08508743A (en)
CN (1) CN1120845A (en)
AU (1) AU688316B2 (en)
CA (1) CA2158972A1 (en)
CZ (1) CZ267695A3 (en)
FI (1) FI954852A0 (en)
HU (1) HUT74091A (en)
NO (1) NO954091L (en)
NZ (1) NZ265271A (en)
OA (1) OA10236A (en)
PL (1) PL311083A1 (en)
SK (1) SK125495A3 (en)
WO (1) WO1994024151A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073089C (en) * 1993-12-28 2001-10-17 盐野义制药株式会社 Novel benzodizaepine derivative
DE69724644T4 (en) * 1996-12-10 2006-08-10 Zeria Pharmaceutical Co., Ltd. 1,5-benzodiazepine derivatives
US6444849B1 (en) 1997-06-25 2002-09-03 Mitsubishi Chemical Corporation Amide derivatives
JP2000026434A (en) 1998-06-05 2000-01-25 Zeria Pharmaceut Co Ltd New 1,5-benzodiazepine derivative
EP1142868A4 (en) * 1998-12-22 2004-09-29 Mitsubishi Chem Corp Amide derivatives
GB201414116D0 (en) 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
EP4041722A4 (en) 2019-10-07 2023-12-13 Kallyope, Inc. Gpr119 agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (en) * 1988-12-29 1994-01-21 Roussel Uclaf NOVEL 2,4-DIOXO 2,3,4,5-TETRAHYDRO 1H-1,5-BENZODIAZEPINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS
FR2659653B1 (en) * 1990-03-13 1992-05-22 Rhone Poulenc Sante DERIVATIVES OF UREA, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
WO1994024151A1 (en) 1994-10-27
JPH08508743A (en) 1996-09-17
CA2158972A1 (en) 1994-10-27
NO954091D0 (en) 1995-10-13
CZ267695A3 (en) 1996-04-17
SK125495A3 (en) 1996-06-05
CN1120845A (en) 1996-04-17
OA10236A (en) 1997-10-07
NZ265271A (en) 1997-06-24
HUT74091A (en) 1996-11-28
HU9502977D0 (en) 1995-12-28
AU688316B2 (en) 1998-03-12
EP0694040A1 (en) 1996-01-31
PL311083A1 (en) 1996-02-05
FI954852A0 (en) 1995-10-12
NO954091L (en) 1995-12-13
AU6567594A (en) 1994-11-08

Similar Documents

Publication Publication Date Title
FI954853A (en) 1,5-Benzodiazepine derivatives with CCK antagonist or agonist activity
ZA954315B (en) Gastrin and cck antagonists
HUP9802678A3 (en) Bicyclic amino derivatives and pgd2 antagonist containing the same
LV11526A (en) Benzodiazepines with antiarrhythmic agents
EP0636892A3 (en) Electrostatic voltmeter.
AU3461293A (en) Benzodiazepine derivatives, as CCK and gastrin antagonists
DE69413405D1 (en) 1,5-BENZODIAZEPINE DERIVATIVES USED AS CCK OR GASTRINE ANTAGONISTS
AP9801289A0 (en) Proc ss fo prep ring ,4-di ydroxypy-ridine and 2,4-dihydroxy-3-nitropyridine
DE69401247D1 (en) HINGE ARRANGEMENT
FI954852A (en) 1,5-Benzodiazepine derivatives with CCK and / or gastrin antagonist activity
EP0662964A1 (en) Heterocyclic amines having colmodulin antagonist properties.
DE69416082D1 (en) Hinge set
NO912772D0 (en) PYRAZOLIDINON CCK, GASTRIN ANTAGONISTS AND PHARMACEUTICAL FORMS THEREOF.
DE69531586D1 (en) Immunosuppressive cyclolignan derivatives
NO933444D0 (en) LINE ARRANGEMENT
AU7228994A (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
GB9502503D0 (en) Gastrin and CCK antagonists
FR2710560B1 (en) Multiple reduction airbrush.
FR2690753B3 (en) PRINTER TESTER.
KR950006628U (en) Inclined hinge
GB9312311D0 (en) New benzodiazepine derivatives
FI1022U1 (en) Sits Foer roddbaotar
KR950020747U (en) Stamper Plating Ring
FI99004C (en) Gangway with several uses